Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Torresi

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Hepatology (Baltimore, Md.)|March 30, 2007
A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virusJoseph Torresi, Owen M Stock, Alexandra E Fischer, et al.
Journal of Travel Medicine|April 13, 2013
Low risk of Japanese encephalitis in short-term Australian travelers to AsiaIrani Ratnam, Karin Leder, Jim Black, et al.
Viral Immunology|March 1, 2018
Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 AgonistsDale Christiansen, Linda Earnest-Silveira, Brendon Chua, et al.
The Journal of General Virology|June 29, 2014
Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosisEu Jin Lim, Korri El Khobar, Ruth Chin, et al.
The Journal of Infection|June 26, 2009
A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellersAshwin Swaminathan, Joseph Torresi, Patricia Schlagenhauf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiencyClaire L Gordon, Kath Langan, Patrick G P Charles, et al.
Frontiers in Immunology|June 11, 2019
A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated MiceMakutiro Ghislain Masavuli, Danushka K Wijesundara, Alexander Underwood, et al.
Vaccine|January 20, 2007
Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance NetworkPhilippe Gautret, Eli Schwartz, Marc Shaw, et al.
Vaccine|December 25, 2015
Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategyAnuj Kumar, Soma Das, Ranajoy Mullick, et al.
Frontiers in Microbiology|December 21, 2020
Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3Zelalem A Mekonnen, Makutiro G Masavuli, Wenbo Yu, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|March 30, 2007
A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virusJoseph Torresi, Owen M Stock, Alexandra E Fischer, et al.
Journal of Travel Medicine|April 13, 2013
Low risk of Japanese encephalitis in short-term Australian travelers to AsiaIrani Ratnam, Karin Leder, Jim Black, et al.
Viral Immunology|March 1, 2018
Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 AgonistsDale Christiansen, Linda Earnest-Silveira, Brendon Chua, et al.
The Journal of General Virology|June 29, 2014
Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosisEu Jin Lim, Korri El Khobar, Ruth Chin, et al.
The Journal of Infection|June 26, 2009
A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellersAshwin Swaminathan, Joseph Torresi, Patricia Schlagenhauf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiencyClaire L Gordon, Kath Langan, Patrick G P Charles, et al.
Frontiers in Immunology|June 11, 2019
A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated MiceMakutiro Ghislain Masavuli, Danushka K Wijesundara, Alexander Underwood, et al.
Vaccine|January 20, 2007
Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance NetworkPhilippe Gautret, Eli Schwartz, Marc Shaw, et al.
Vaccine|December 25, 2015
Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategyAnuj Kumar, Soma Das, Ranajoy Mullick, et al.
Frontiers in Microbiology|December 21, 2020
Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3Zelalem A Mekonnen, Makutiro G Masavuli, Wenbo Yu, et al.
Pageof 13